Cyclobenzaprine Hydrochloride
NDC Package 64376-178-61

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cyclobenzaprine Hydrochloride is a . Marketed by Boca Pharmacal, Llc, this product is identified by NDC 64376-178 and is authorized under FDA application ANDA091281.

Identification & Billing

NDC Package Code
64376-178-61
Package Description
60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Product Code
64376-178
11-Digit Billing Format
64376017861

Clinical Specifications

Proprietary Name
Cyclobenzaprine Hydrochloride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Boca Pharmacal, Llc
FDA Application #
ANDA091281
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-31-2013
End Marketing Date
10-11-2013
Listing Expiration
10-11-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64376-178-61 identifies a specific commercial package of 60 capsule, extended release in 1 bottle of Cyclobenzaprine Hydrochloride, labeled by Boca Pharmacal, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Boca Pharmacal, Llc on January 31, 2013. The current certification is valid through October 11, 2013.

How is this Boca Pharmacal, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64376017861. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64376-178-61
11-Digit CMS (5-4-2)
64376-0178-61

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.